Use of a phosphopeptide as a ligand to purify phospholipase A(2) from the venom of Crotalus durisuss terrificus by affinity chromatography
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Authors: Saavedra, Soledad L.; Acosta, Gerardo; Avila, Lucia; Giudicessi, Silvana L.; Camperi, Silvia A.; Albericio, Fernando; Cascone, Osvaldo; Martinez Ceron, Maria C.
Abstract
The venom of Crotalus durissus terrificus (Cdt) is a source of a wide variety of toxins, some of them with interesting pharmacological applications. Of these toxins, the phospholipase A(2) (PLA(2)) subunit of crotoxin (Ctx) has been studied for its potential as an antiviral and antibacterial agent. Peptides have proven useful ligands for the purification of numerous molecules, including antibodies, toxins, enzymes and other proteins. Here, we sought to use a phosphopeptide (P-Lys) as a ligand for PLA(2) purification. P-Lys was synthesized in solid phase on Rink-Amide-ChemMatrix resin, immobilized on NHS-agarose, and then evaluated as a chromatographic matrix. Under the best conditions, total protein adsorption reached 39% and only the eluate fraction presented PLA(2) activity. Analysis of the eluate by SDS-PAGE showed three bands, one corresponding to the molecular weight of PLA(2) (14 kDa). Said bands were analyzed by mass spectrometry and identified as PLA(2) and its multimers. The final product showed a purity of over 90%. In addition, slightly changing the process conditions also allowed the isolation of crotamine.
Selective Cyclized alpha-Melanocyte-Stimulating Hormone Derivative with Multiple N-Methylations for Melanoma Imaging with Positron Emission Tomography
ACS OMEGA
Authors: Zhang, Chengcheng; Zhang, Zhengxing; Zeisler, Jutta; Colpo, Nadine; Lin, Kuo-Shyan; Benard, Francois
Abstract
In this study, we designed and evaluated a novel alpha-melanocyte-stimulating hormone derivative with four N-methylations for melanocortin 1 receptor-targeted melanoma imaging with positron emission tomography (PET). The resulting peptide, DOTA-Pip-Nle(4)-Cyclo [Asp(5)-N-Me-His(6)-D-Phe(7)-N-Me -Arg(8)-N-Me-Trp(9)-N-Me-Lys(10)]alpha MSH4-10-NH2 (CCZ01099), showed high receptor selectivity, greatly improved stability, and rapid internalization. [Ga-68]Ga-CCZ01099 showed clear tumor visualization and excellent tumor-to-normal tissue contrast with PET imaging in a preclinical melanoma model. Therefore, CCZ01099 is a promising compound for imaging and potentially radioligand therapy for melanoma.